POET 2024 Preliminary Agenda
THURSDAY, NOVEMBER 7th
|
| 7:45 AM | Registration |
| 8:00 AM – 9:00 AM | Continental Breakfast |
| 9:00 AM – 9:40 AM | Welcome Address – Dr. Steve Yip & Dr. Pinaki Bose
|
| 9:40 AM – 10:20 AM | Chair: Dr. Steve Jones Somatic Mutations in Ageing and Disease KEYNOTE SPEAKER – Dr. Peter Campbell |
| 10:20 AM – 10:35 AM | Questions & Answer |
| 10:35 AM – 11:50 AM | SESSION 1: Precision Oncology, Clinical Trials & RWE Chair: Dr. Steven Yip |
| 10:35 AM – 10:55 AM | Innovations and Intersections in Oncology Real-World Evidence (RWE) – Dr. Winson Cheung, University of Calgary |
| 10:55 AM – 11:00 AM | Q&A |
| 11:00 AM – 11:20 AM | Targeting the Tumor Microenvironment of Hodgkin Lymphoma – Dr. Christian Steidl, BC Cancer Research Centre, BC |
| 11:20 AM – 11:25 AM | Q&A |
| 11:25 AM – 11:50 AM | Coffee Break |
| 11:50 AM – 12:40 PM | SESSION 1 Continued |
| 11:50 AM – 12:10 PM | Precision Oncology, Clinical Trials & RWE – Dr. Janessa Laskin, University of British Columbia, BC |
| 12:20 PM – 12:15 PM | Q&A |
| 12:15 PM – 12:35 PM | Lung Cancer and Biomarker Driven Research – Dr. Natasha Leighl, University of Toronto, ON |
| 12:35 PM – 12:40 PM | Q&A |
| 12:40 PM – 1:00 PM | Evolution and New Trends in Early Drug Development in Oncology – Dr. Quincy Chu, University of Alberta, AB |
| 1:00 PM – 1:05 PM | Q&A |
| 1:05 PM – 2:05 PM | Lunch |
| 2:10 PM – 3:00 PM | SESSION 2: Immuno-Oncology / Cell Therapy Chair: Dr. Nicolas Jacquelot |
| 2:10 PM –2:30 PM | Monitoring Anti-Cancer Immune Responses Through T Cell Receptor Sequencing – Dr. Trevor Pugh, Princess Margaret Cancer Centre, ON |
| 2:30 PM – 2:35 PM | Q&A |
| 2:35 PM – 2:55 PM | Dissecting Spatial Relationships Within the Tumour Microenvironment for Predictive Value – Dr. Logan Walsh, McGill University, QC |
| 2:55 PM – 3:00 PM | Q&A |
| 3:00 PM – 3:20 PM | Coffee Break |
| 3:20 PM – 4:40 PM | SESSION 2 Continued |
| 3:20 PM – 3:40 PM | Tissue-Resident Lymphocytes in Cancer – Dr. Tim Halim, University of Cambridge, UK |
| 3:40 PM – 3:45 PM | Q&A |
| 3:45 PM – 4:05 PM | More Than a Ligand: New Insights Into PD-L1 Immunobiology – Dr. Michele Ardolino, University of Ottawa, ON |
| 4:05 PM – 4:10 PM | Q&A |
| 4:10 PM – 4:30 PM | Harnessing Type 2 Innate Lymphoid Cells in Cancer – Dr. Nicolas Jacquelot, Arnie Charbonneau Cancer Institute, AB |
| 4:30 PM – 4:35 PM | Q&A |
| 4:35 PM – 4:45 PM | Day 1 Closing Remarks – Drs. Steven Yip & Pinaki Bose |
| 4:45 PM – 5:30 PM | POET Reception Sky Garden, 54th Floor, Bow Tower |
| 5:30 PM – 8:20 PM | POET Welcome Dinner
INNOVATION IN PRECISION ONCOLOGY Co-Chairs Dr. Steven Yip & Dr. Pinaki Bose Twenty-Five Years in Precision Oncology – Could I Have Been More Inaccurate? – Dr. David Huntsman, Chew Wei Professor of Gynaecologic Oncology, BC |
FRIDAY, NOVEMBER 8th
|
| 8:00 AM – 9:00 AM | Registration & Continental Breakfast |
| 9:00 AM – 9:05 AM | Opening Remarks |
| 9:05 AM – 10:20 AM | SESSION 3: Precision Oncology and Artificial Intelligence (20min + 5min Q&A) Chair: Dr. Omar Khan |
| 9:05 AM – 9:25 AM | Presentation TBD – Dr. Faisal Mahmood, Harvard Medical School, USA |
| 9:25 AM – 9:30 AM | Q&A |
| 9:30 AM – 9:50 AM | Presentation TBD – Dr. Omar Khan, Tom Baker Cancer Centre, AB |
| 9:50 AM – 9:55 AM | Q&A |
| 9:55 AM – 10:15 AM | Revolutionizing Cancer Biomarker Discovery with Machine Learning: The Future of Precision Oncology – Dr. Ali Bashashati, University of British Columbia, BC |
| 10:15 AM – 10:20 AM | Q&A |
| 10:20 AM – 10:40 AM | Coffee Break |
| 10:40 AM – 11:55 AM | SESSION 3 Continued: |
| 10:40 AM – 11:00 AM | The Current and Future Role of Artificial Intelligence for Lung Cancer Screening and Early Detection – Dr. Matthew Warkentin, University of Calgary, AB |
| 11:00 AM – 11:05 AM | Q&A |
| 11:05 AM – 11:25 AM | Presentation TBD – Dr. Tejas Patil, University of Colorado |
| 11:25 AM – 11:30 AM | Q&A |
| 11:30 AM – 11:50 AM | ctDNA Determinants of Resistance to Radioligand Therapy in Prostate Cancer – Dr. Alex Wyatt, Vancouver Prostate Centre, BC |
| 11:50 AM – 11:55 AM | Q&A |
| 12:00 PM – 1:30 PM | Lunch |
| 1:30 PM – 2:45 PM | SESSION 4: Liquid Biopsy and Precision Oncology (20min + 5 Q&A) Chair: Dr. Pinaki Bose |
| 1:30 PM – 1:50 PM | Long Read Sequencing to Characterize Human Cancers and their Epigenomes – Dr. Steve Jones, Canada’s Michael Smith Genome Centre, BC |
| 1:50 PM – 1:55 PM | Q&A |
| 1:55 PM – 2:15 PM | Dynamic Risk Stratification in Head & Neck Cancer Using Circulating Tumour DNA – Dr. Scott Bratman, Princess Margaret Cancer Centre, ON |
| 2:15 PM – 2:20 PM | Q&A |
| 2:20 PM – 2:50 PM | Coffee Break |
| 2:50 PM – 4:15 PM | SESSION 4 Continued: |
| 2:50 PM – 3:10 PM | Towards Multi-Modal Liquid Biopsies – Dr. Florent Mouliere, Cancer Research UK, UK |
| 3:10 PM – 3:15 PM | Q&A |
| 3:15 PM – 3:35 PM | Towards ctDNA-Guided Treatment of Bladder Cancer – Dr. Lars Dyrskjøt Andersen, Aarhus University Hospital, Denmark |
| 3:35 PM – 3:40 PM | Q&A |
| 3:40 PM – 4:00 PM | ctDNA for MRD and a Pathway to Cure – Dr. James Hadfield, Cambridge Science Park, UK |
| 4:00 PM – 4:05 PM | Q&A |
| 4:05 PM | Day 2 Closing Remarks – POET Chairs, Dr. Steven Yip & Dr. Pinaki Bose |
